未登录

R

R. Hansen

Rigshospitalet

H指数:15

被引数:640

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sustained effects on immune cell subsets and autoreactivity in multiple sclerosis patients treated with oral cladribine

口服克拉屈滨治疗的多发性硬化症患者对免疫细胞亚群和自身反应性的持续影响

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-160

OAAI

CD11c+ B cells in relapsing-remitting multiple sclerosis and effects of anti-CD20 therapy

CD11c b细胞在复发-缓解型多发性硬化中的作用及anti-CD20治疗的影响

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY

IF3.9

2024-02-084

OA

Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-09-068

OAAI

Intrathecal CD8+CD20+ T Cells in Primary Progressive Multiple Sclerosis

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2023-09-016

OAAI

Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis

ANNALS OF NEUROLOGY

IF7.7

2023-05-265

OAAI

Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2022-09-0115

OAAI

Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2022-07-0124

OAAI

Peripheral helper T cells in the pathogenesis of multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL

IF5

2022-02-036

PRE

Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis A Randomized, Controlled Trial

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

IF7.5

2021-09-0116

OAAI

Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

ANNALS OF NEUROLOGY

IF7.7

2019-11-2731

PREAI

Fully automatic detection of heart irradiation in cine MV images during breast cancer radiotherapy

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-010

OAAI

Experimental validation of an MLC tracking treatment simulator with dose reconstruction

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-010

OAAI

Detailed PTV margin assessment for liver SBRT with CBCT-guidance or realtime monitoring and gating

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-011

OAAI

Dose-guided motion management during liver SBRT delivery using real-time reconstructed tumor DVHs

RADIOTHERAPY AND ONCOLOGY

IF5.3

2019-04-010

OAAI

Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis

IF11.7

2018-12-1787

OAAI

Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL

IF5

2018-07-2517

PREAI

Tumor volume and diffusivity during RT show non-intuitive interrelation with treatment outcome

RADIOTHERAPY AND ONCOLOGY

IF5.3

2018-04-010

OAAI

First clinical demonstration of online real-time liver tumor motion monitoring on a standard linac

RADIOTHERAPY AND ONCOLOGY

IF5.3

2018-04-010

OAAI

Intra-treatment diffusion MRI for predicting radiotherapy response in head and neck cancer patients

RADIOTHERAPY AND ONCOLOGY

IF5.3

2017-05-010

OAAI

Real-time gamma evaluations of motion induced dose errors as QA of liver SBRT tumour tracking

RADIOTHERAPY AND ONCOLOGY

IF5.3

2017-05-010

OAAI